RE:RE:RE:RE:RE:panobinostat, lomustine, xB3-bevacizumabcraighenry wrote: JDavenport wrote: I confess, craig, I lied. It's only
909,652,073 shares.
909,652,073 isn't even close to a billion. jd
Absolutely clueless JD.
Lets see:
MTP currently has 3.94 Million shares outstanding plus approx 76 million issued for the Bioasis merger (footnote below)
To me that is approx. 79.4 million shares outstanding.
No wonder DR dropped your butt. Absolute incompetence. She saw that a mile a way.
John, there is a reason GD is still employed by Bioasis and you aren't!
"The Acquisition consideration will be satisfied by the issue of, in aggregate, 75,884,553 new Ordinary Shares"
I left out the warrant structure because because there are a lot of factors at play.
But Im sure you understand. LoL!
Midatech is also pleased to announce a two-stage fundraise of approximately US$10.0 million (c.£8.2 million) gross proceeds, comprising of: (i) gross proceeds of approximately US$0.4 (c.£0.3 million) raised pursuant to the Registered Direct Offering in the United States utilising the Company's existing share capital authorities, via the issuance of 9,849,325 new Ordinary Shares at a price of approximately 3.3 pence per Ordinary Share (equivalent to 393,973 new ADSs (the "Registered ADSs") at a price of US$1.00 per ADS); and (ii) gross proceeds of approximately US$9.6 million (c.£7.9 million) pursuant to the Private Placement, via the issuance of 14,602,050 new Ordinary Shares (equivalent to 584,082 new ADSs, the "Unregistered ADSs"); 9,021,945 pre-funded warrants to purchase 9,021,945 ADSs; 10,000,000 A Warrants to purchase up to 10,000,000 ADSs; and 10,000,000 B Warrants to purchase up to 10,000,000 ADSs.